Cantor Fitzgerald Starts Bellicum Pharmaceuticals (BLCM) at Buy
Tweet Send to a Friend
Cantor Fitzgerald initiates coverage on Bellicum Pharmaceuticals (NASDAQ: BLCM) with a Buy rating and a price target of $32.00.Analyst Elemer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE